Testosterone Therapy in Castration Resistant Prostate Cancer

Summary

This is an open-labeled, single-arm, interventional pilot study. It is being done to determine the feasibility of the administration of transdermal testosterone alternating with enzalutamide, as well as the safety and efficacy.

Timeline

Start

2019-01-18

Primary completion

2024-08-14

Completion

2025-09-30

Drugs

Indications